Silverstein M J, Rosser R J, Gierson E D, Waisman J R, Gamagami P, Hoffman R S, Fingerhut A G, Lewinsky B S, Colburn W, Handel N
Cancer. 1987 May 15;59(10):1819-24. doi: 10.1002/1097-0142(19870515)59:10<1819::aid-cncr2820591023>3.0.co;2-v.
One hundred patients with intraductal breast carcinoma (DCIS) were treated with either mastectomy (49 patients) or radiation therapy (51 patients). All patients underwent axillary lymph node dissection (average number of nodes removed, 16) as part of their treatment. No patient had any positive axillary lymph nodes. There has been one recurrence in each treatment group (median follow-up, 27 months) and no deaths. Intraductal breast carcinoma has little potential for metastasis to axillary lymph nodes.
100例乳腺导管内癌（DCIS）患者接受了乳房切除术（49例）或放射治疗（51例）。所有患者均接受腋窝淋巴结清扫术（平均清扫淋巴结数量为16个）作为其治疗的一部分。没有患者腋窝淋巴结呈阳性。每个治疗组均有1例复发（中位随访时间为27个月），且无死亡病例。乳腺导管内癌转移至腋窝淋巴结的可能性很小。
